Literature DB >> 12411282

Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.

Namita Sood1, William D Bennett, Kirby Zeman, James Brown, Carla Foy, Richard C Boucher, Michael R Knowles.   

Abstract

Mucociliary clearance is determined by ciliary activity and rheology of airway surface liquid. To test the hypothesis that mucociliary clearance would increase after inhalation of an osmotically active agent that would increase the volume of airway surface liquid, we measured mucociliary clearance in 16 normal subjects after inhalation of varying tonicities of saline alone, and after pretreatment with a Na+ channel blocker (amiloride). Subjects inhaled vehicle (0.12% saline) or amiloride, followed by inhalation of 0.12, 0.9, or 7% saline. Subsequently, mucociliary clearance rates were measured by gamma scintigraphy of inhaled 99mTc Fe2O3. Mucociliary clearance of whole and peripheral lung was increased (approximately twofold) after inhalation of increasing concentrations of saline (p < 0.04). Pretreatment with amiloride increased mucociliary clearance rates (approximately twofold) after inhalation of 0.12 and 0.9% saline (p < 0.05), but not 7% saline. The rates of mucociliary clearance by pretreatment with amiloride and 7% saline alone (approximately 1.4% per minute) approached the rapid mucociliary clearance rates (approximately 2.0% per minute) reported in systemic pseudohypoaldosteronism, which has loss-of-function mutations of the epithelial Na+ channel and an increased volume of airway surface liquid. We conclude that maneuvers that increase the volume of airway surface liquid are associated with increased rates of mucociliary clearance in normal subjects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411282     DOI: 10.1164/rccm.200204-293OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  Effective mucus clearance is essential for respiratory health.

Authors:  Scott H Randell; Richard C Boucher
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-09       Impact factor: 6.914

2.  Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.

Authors:  Timothy E Corcoran; Joseph E Godovchik; Karl H Donn; David R Busick; Jennifer Goralski; Landon W Locke; Matthew R Markovetz; Michael M Myerburg; Ashok Muthukrishnan; Lawrence Weber; Ryan T Lacy; Joseph M Pilewski
Journal:  Pediatr Pulmonol       Date:  2017-07-24

3.  Comparing the Efficacy of 7%, 3% and 0.9% Saline in Moderate to Severe Bronchiolitis in Infants.

Authors:  Seçil Köse; Ahmet Şehriyaroğlu; Feyza Esen; Ahmet Özdemir; Zehra Kardaş; Umut Altuğ; Esef Karakuş; Alper Özcan; Ali Fatih Kısaarslan; Ferhan Elmalı; Yasemin Altuner Torun; Mehmet Köse
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

4.  A role for two-pore K⁺ channels in modulating Na⁺ absorption and Cl⁻ secretion in normal human bronchial epithelial cells.

Authors:  Ke-Qing Zhao; Guoxiang Xiong; Morgan Wilber; Noam A Cohen; James L Kreindler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

5.  Duration of action of hypertonic saline on mucociliary clearance in the normal lung.

Authors:  W D Bennett; J Wu; F Fuller; J R Balcazar; K L Zeman; H Duckworth; K H Donn; T G O'Riordan; R C Boucher; S H Donaldson
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

Review 6.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

Review 7.  Hypertonic Saline for the Treatment of Bronchiolitis in Infants and Young Children: A Critical Review of the Literature.

Authors:  Jeffrey Baron; Gladys El-Chaar
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

Review 8.  Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic Fibrosis.

Authors:  William D Bennett; Ashley G Henderson; Scott H Donaldson
Journal:  Ann Am Thorac Soc       Date:  2016-04

Review 9.  Therapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis.

Authors:  George M Solomon; S Vamsee Raju; Mark T Dransfield; Steven M Rowe
Journal:  Ann Am Thorac Soc       Date:  2016-04

10.  Inhibitory effects of hypertonic saline on P. aeruginosa motility.

Authors:  Viktória Havasi; Casey O Hurst; Travis C Briles; Fan Yang; David G Bains; Daniel J Hassett; Eric Sorscher
Journal:  J Cyst Fibros       Date:  2008-01-31       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.